title: Etanercept and infliximab associated with cutaneous vasculitis.
authors.forename: M E
authors.initials: ME
authors.lastname: McCain
authors.forename: R J
authors.initials: RJ
authors.lastname: Quinet
authors.forename: W E
authors.initials: WE
authors.lastname: Davis
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000188:drug therapy*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D000068800:Etanercept; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D014657:Vasculitis / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab; D000068800:Etanercept